{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/24/3316738/0/en/Cognition-Therapeutics-Aligns-on-Key-Aspects-of-Pivotal-Study-for-Zervimesine-CT1812-in-DLB-Psychosis-Following-Receipt-of-FDA-Meeting-Minutes.html", "message": "News view counter 813955 successfully enlarged"}